Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Punit Dhillon Insider Profile
4 Followers
Punit Dhillon, Director at OncoSec Medical, holds 485.26K shares in OncoSec Medical (Ticker: ONCSQ), holds ― shares in Arch Therapeutics (Ticker: ARTH), holds 397.01K shares in Skye Bioscience (Ticker: SKYE).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
+1.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Punit Dhillon holds in companies
Most Profitable Insider Trade
The most profitable trade made by Punit Dhillon
Punit Dhillon's Trading History
OncoSec Medical
Jul 06, 2018
Director
Uninformative Buy
303.95K
$14.07K
Arch Therapeutics
―
Director
―
―
Skye Bioscience
Mar 01, 2024
CEO, Director
Uninformative Buy
―
$5.08M
Inovio Pharmaceuticals
―
VP, Finance & Operations
―
$2.14K
List of latest transactions for each holding click on a transaction to see Punit Dhillon's performance on stock
You May Also Like
Punit Dhillon insider profile FAQ
What is the percentage of profitable transactions made by Punit Dhillon?
The percentage of profitable transactions made by Punit Dhillon is 25%.
What is the average return per transaction made by Punit Dhillon?
The average return per transaction made by Punit Dhillon is 1.40%.
What stocks does Punit Dhillon hold?
Punit Dhillon holds: ONCSQ, ARTH, SKYE, INO stocks.
What was Punit Dhillon’s latest transaction?
Punit Dhillon latest transaction was an Uninformative Buy of $303.95K.
What was Punit Dhillon's most profitable transaction?
Punit Dhillon’s most profitable transaction was an Informative Buy of SKYE stock on August 11, 2020. The return on the trade was 194.00%.
What is Punit Dhillon's role in OncoSec Medical?
Punit Dhillon's role in OncoSec Medical is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.